Market Cap ₹2910 Cr.
Stock P/E 16.8
P/B 4
Current Price ₹1655
Book Value ₹ 411
Face Value 10
52W High ₹1756.1
Dividend Yield 5.92%
52W Low ₹ 793.1
INEOS Styrolution India Ltd is engaged in manufacturing, trading and selling of engineering thermoplastics. The Company is a styrenics dealer with a focal point on styrene monomer, polystyrene, acrylonitrile butadiene styrene (ABS) standard and styrenics specialties. It offers styrenic programs for numerous products across a number of industries, which includes automotive, electronics, household, healthcare and packaging. It manufactures and sells styrene acrylonitrile copolymers (SAN) resins, polystyrene and ABS resins. It manufactures ABS underneath two brands, together with Absolac, which is a plastic resin made from acrylonitrile, butadiene and styrene, and Novodur, that's a brand of ABS copolymers. Absolan is its brand of polymerized plastic resin, which is made out of styrene and acrylonitrile. Its Luran S products are ASA/polycarbonate (ASA/PC) and acrylonitrile styrene acrylate (ASA). It additionally manufactures general purpose polystyrene (GPPS) and high impact polystyrene (HIPS).
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 512 | 624 | 650 | 550 | 557 | 615 | 544 | 595 | 485 | 599 |
Other Income | 2 | 1 | 6 | 4 | 2 | 3 | 2 | 3 | 2 | 2 |
Total Income | 514 | 625 | 656 | 554 | 560 | 618 | 546 | 598 | 486 | 601 |
Total Expenditure | 429 | 483 | 529 | 510 | 508 | 549 | 493 | 512 | 427 | 527 |
Operating Profit | 84 | 142 | 127 | 43 | 51 | 69 | 53 | 86 | 60 | 74 |
Interest | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 9 | 9 | 9 | 10 | 9 | 10 | 9 | 9 | 9 | 9 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 73 | 130 | 116 | 32 | 40 | 58 | 43 | 76 | 50 | 64 |
Provision for Tax | 26 | 31 | 29 | 9 | 10 | 16 | 11 | 19 | 15 | 15 |
Profit After Tax | 47 | 99 | 87 | 24 | 30 | 42 | 32 | 56 | 35 | 49 |
Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
Profit After Adjustments | 47 | 99 | 87 | 24 | 30 | 42 | 32 | 56 | 35 | 49 |
Adjusted Earnings Per Share | 27 | 56.3 | 49.4 | 13.4 | 17.2 | 24.1 | 18.4 | 32.1 | 19.9 | 28.1 |
#(Fig in Cr.) | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 989 | 1114 | 1463 | 1584 | 1482 | 1895 | 2091 | 1579 | 1631 | 2179 | 2372 | 2223 |
Other Income | 11 | 11 | 5 | 3 | 4 | 7 | 13 | 7 | 13 | 14 | 15 | 9 |
Total Income | 1000 | 1125 | 1468 | 1587 | 1486 | 1902 | 2104 | 1586 | 1645 | 2193 | 2387 | 2231 |
Total Expenditure | 890 | 1031 | 1380 | 1488 | 1347 | 1760 | 2083 | 1514 | 1218 | 1704 | 2097 | 1959 |
Operating Profit | 110 | 94 | 88 | 99 | 139 | 142 | 21 | 72 | 427 | 488 | 290 | 273 |
Interest | 4 | 3 | 15 | 11 | 14 | 14 | 13 | 16 | 15 | 8 | 5 | 4 |
Depreciation | 14 | 13 | 21 | 27 | 25 | 25 | 27 | 32 | 36 | 38 | 38 | 36 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38 | 0 | 0 | 0 | 0 |
Profit Before Tax | 93 | 77 | 52 | 60 | 100 | 103 | -18 | -13 | 376 | 443 | 247 | 233 |
Provision for Tax | 30 | 27 | 17 | -4 | 31 | 37 | -6 | -4 | 96 | 120 | 64 | 60 |
Profit After Tax | 63 | 51 | 35 | 64 | 69 | 66 | -12 | -10 | 280 | 323 | 183 | 172 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 63 | 51 | 35 | 64 | 69 | 66 | -12 | -10 | 280 | 323 | 183 | 172 |
Adjusted Earnings Per Share | 35.9 | 28.7 | 19.9 | 36.3 | 39.4 | 37.7 | -7.1 | -5.4 | 159.3 | 183.4 | 104.1 | 98.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 9% | 15% | 5% | 9% |
Operating Profit CAGR | -41% | 59% | 15% | 10% |
PAT CAGR | -43% | 0% | 23% | 11% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 105% | 10% | 26% | 14% |
ROE Average | 23% | 33% | 19% | 15% |
ROCE Average | 32% | 42% | 25% | 19% |
#(Fig in Cr.) | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 435 | 477 | 504 | 527 | 587 | 645 | 623 | 609 | 889 | 856 | 715 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 23 | 89 | 63 | 33 | 10 | 10 |
Other Non-Current Liabilities | 259 | 286 | 298 | 23 | 36 | 48 | 27 | 89 | 86 | 75 | 58 |
Total Current Liabilities | 171 | 349 | 300 | 376 | 458 | 394 | 382 | 294 | 305 | 291 | 480 |
Total Liabilities | 865 | 1112 | 1102 | 925 | 1081 | 1110 | 1122 | 1055 | 1313 | 1232 | 1263 |
Fixed Assets | 124 | 136 | 217 | 241 | 219 | 214 | 200 | 365 | 369 | 343 | 309 |
Other Non-Current Assets | 285 | 342 | 401 | 41 | 58 | 190 | 256 | 165 | 40 | 29 | 31 |
Total Current Assets | 457 | 634 | 484 | 643 | 804 | 705 | 666 | 526 | 904 | 860 | 922 |
Total Assets | 865 | 1112 | 1102 | 925 | 1081 | 1110 | 1122 | 1055 | 1313 | 1232 | 1263 |
#(Fig in Cr.) | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 29 | 29 | 37 | 20 | 25 | 16 | 40 | 45 | 3 | 139 | 166 |
Cash Flow from Operating Activities | -24 | 50 | 20 | 28 | -16 | 173 | -36 | 166 | 385 | 356 | 270 |
Cash Flow from Investing Activities | 98 | -57 | -51 | -6 | -15 | -21 | -93 | -84 | -112 | 83 | -136 |
Cash Flow from Financing Activities | -73 | 13 | -1 | -18 | 22 | -127 | 135 | -124 | -137 | -412 | -198 |
Net Cash Inflow / Outflow | 0 | 7 | -32 | 5 | -9 | 24 | 5 | -42 | 136 | 27 | -63 |
Closing Cash & Cash Equivalent | 29 | 37 | 5 | 25 | 16 | 40 | 45 | 3 | 139 | 166 | 103 |
# | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 35.9 | 28.72 | 19.92 | 36.3 | 39.4 | 37.66 | -7.09 | -5.42 | 159.34 | 183.41 | 104.07 |
CEPS(Rs) | 43.64 | 36.34 | 32.04 | 51.77 | 53.77 | 52.08 | 8.22 | 12.53 | 179.83 | 204.81 | 125.69 |
DPS(Rs) | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 0 | 10 | 297 | 104 |
Book NAV/Share(Rs) | 247.38 | 271.39 | 286.49 | 299.5 | 333.82 | 366.5 | 354.41 | 346.47 | 505.4 | 487.01 | 406.44 |
Core EBITDA Margin(%) | 8.96 | 6.62 | 5.05 | 5.41 | 8.1 | 6.93 | 0.38 | 4.11 | 25.23 | 21.7 | 11.53 |
EBIT Margin(%) | 8.73 | 6.41 | 4.04 | 4.03 | 6.83 | 5.99 | -0.28 | 0.15 | 23.82 | 20.61 | 10.57 |
Pre Tax Margin(%) | 8.41 | 6.16 | 3.14 | 3.39 | 6.01 | 5.29 | -0.88 | -0.85 | 22.93 | 20.24 | 10.35 |
PAT Margin (%) | 5.7 | 4.02 | 2.13 | 3.6 | 4.15 | 3.39 | -0.6 | -0.6 | 17.09 | 14.75 | 7.67 |
Cash Profit Margin (%) | 6.93 | 5.08 | 3.42 | 5.13 | 5.66 | 4.69 | 0.69 | 1.39 | 19.28 | 16.47 | 9.26 |
ROA(%) | 7.63 | 5.11 | 3.16 | 6.3 | 6.91 | 6.05 | -1.12 | -0.87 | 23.66 | 25.34 | 14.67 |
ROE(%) | 15.49 | 11.07 | 7.14 | 12.39 | 12.44 | 10.75 | -1.97 | -1.55 | 37.41 | 36.96 | 23.3 |
ROCE(%) | 19.08 | 15.08 | 11.28 | 10.93 | 15.27 | 15.12 | -0.71 | 0.29 | 45.32 | 49.86 | 31.72 |
Receivable days | 49.28 | 57.45 | 46.94 | 43.82 | 48.81 | 43.73 | 41.96 | 46.93 | 53.22 | 51.12 | 47.8 |
Inventory Days | 31.32 | 38.93 | 37.21 | 36.46 | 55.96 | 57.95 | 53.72 | 67.18 | 62.14 | 52.68 | 52.52 |
Payable days | 18.37 | 56.75 | 57.03 | 46.48 | 58.81 | 55.38 | 46.18 | 48.85 | 69.47 | 61.51 | 56.8 |
PER(x) | 20.76 | 14.62 | 33.54 | 15.41 | 17.47 | 22.92 | 0 | 0 | 5.87 | 5.31 | 6.86 |
Price/Book(x) | 3.01 | 1.55 | 2.33 | 1.87 | 2.06 | 2.35 | 1.48 | 1.48 | 1.85 | 2 | 1.76 |
Dividend Yield(%) | 0.54 | 0.95 | 0.6 | 0.72 | 0.58 | 0.46 | 0.38 | 0 | 1.07 | 30.48 | 14.56 |
EV/Net Sales(x) | 1.36 | 0.71 | 0.87 | 0.71 | 0.95 | 0.83 | 0.55 | 0.68 | 0.89 | 0.71 | 0.43 |
EV/Core EBITDA(x) | 12.2 | 8.42 | 14.56 | 11.43 | 10.08 | 11.13 | 54.02 | 14.92 | 3.41 | 3.16 | 3.52 |
Net Sales Growth(%) | 19.77 | 12.65 | 31.3 | 8.24 | -6.41 | 27.86 | 10.3 | -24.47 | 3.32 | 33.56 | 8.87 |
EBIT Growth(%) | 22.2 | -16.64 | -17.4 | 7.53 | 59.26 | 2.49 | -104.96 | 141.43 | 0 | 15.38 | -44.04 |
PAT Growth(%) | 16.98 | -20 | -30.65 | 82.25 | 8.54 | -4.41 | -118.83 | 23.62 | 3042.63 | 15.11 | -43.26 |
EPS Growth(%) | 16.98 | -20 | -30.65 | 82.25 | 8.54 | -4.41 | -118.83 | 23.62 | 3042.63 | 15.11 | -43.26 |
Debt/Equity(x) | 0.15 | 0.19 | 0.22 | 0.32 | 0.36 | 0.16 | 0.43 | 0.28 | 0.06 | 0.01 | 0.01 |
Current Ratio(x) | 2.67 | 1.82 | 1.62 | 1.71 | 1.76 | 1.79 | 1.74 | 1.79 | 2.96 | 2.96 | 1.92 |
Quick Ratio(x) | 2.11 | 1.32 | 1.07 | 1.2 | 1.06 | 1.03 | 0.92 | 0.88 | 2.01 | 1.78 | 1.2 |
Interest Cover(x) | 27.24 | 25.63 | 4.49 | 6.33 | 8.34 | 8.54 | -0.46 | 0.15 | 26.69 | 54.77 | 47.38 |
Total Debt/Mcap(x) | 0.05 | 0.12 | 0.09 | 0.17 | 0.17 | 0.07 | 0.29 | 0.19 | 0.03 | 0.01 | 0.01 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 75 | 75 | 61.19 | 61.19 | 62.73 | 62.73 | 62.73 | 62.73 | 62.73 | 62.73 |
FII | 2.02 | 2.04 | 1.87 | 1.57 | 1.42 | 1.39 | 2.18 | 2.26 | 2.53 | 2.09 |
DII | 3.02 | 2.86 | 4.14 | 4.45 | 4.45 | 4.41 | 4.78 | 4.82 | 5.02 | 4.99 |
Public | 19.96 | 20.1 | 32.79 | 32.78 | 31.4 | 31.47 | 30.31 | 30.19 | 29.72 | 30.19 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.32 | 1.32 | 1.08 | 1.08 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
FII | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 |
DII | 0.05 | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
Public | 0.35 | 0.35 | 0.58 | 0.58 | 0.55 | 0.55 | 0.53 | 0.53 | 0.52 | 0.53 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About